Therapeutic Index [terapeutický index]

topical
6
Persistent link   https://www.medvik.cz/link/D000076162
Definition

An indicator of the benefits and risks of treatment.

DUI
D000076162 MeSH Browser
CUI
M000632369
History note
2018
Public note
2018

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E01 Diagnosis 1 790
E01.789 Prognosis 9 661
E01.789.800 Treatment Outcome 21 703
E01.789.800.190 Disease-Free Survival 1 445
E01.789.800.238 Early Termination of Clinical Trials 16
E01.789.800.262 Pathologic Complete Response 7
E01.789.800.285 Progression-Free Survival 495
E01.789.800.379 Response Evaluation Criteria in Solid Tumors 42
E01.789.800.570 Sustained Virologic Response 19
E01.789.800.665 Therapeutic Index 6
E01.789.800.665.500 Therapeutic Index, Drug 6
E01.789.800.713 Treatment Expectations
E01.789.800.760 Treatment Failure 673

N Health Care
N04 Health Services Administration 1 738
N04.761 Quality of Health Care 2 492
N04.761.559 Outcome and Process Assessment, Health Care 1 870
N04.761.559.590 Outcome Assessment, Health Care 584
N04.761.559.590.800 Treatment Outcome 21 703
N04.761.559.590.800.190 Disease-Free Survival 1 445
N04.761.559.590.800.379 Early Termination of Clinical Trials 16
N04.761.559.590.800.427 Pathologic Complete Response 7
N04.761.559.590.800.474 Progression-Free Survival 495
N04.761.559.590.800.569 Response Evaluation Criteria in Solid Tumors 42
N04.761.559.590.800.665 Sustained Virologic Response 19
N04.761.559.590.800.713 Therapeutic Index 6
N04.761.559.590.800.713.500 Therapeutic Index, Drug 6
N04.761.559.590.800.737 Treatment Expectations
N04.761.559.590.800.760 Treatment Failure 673
N05 Health Care Quality, Access, and Evaluation 685
N05.715 Quality of Health Care 2 492
N05.715.360 Health Care Evaluation Mechanisms 200
N05.715.360.575 Outcome and Process Assessment, Health Care 1 870
N05.715.360.575.575 Outcome Assessment, Health Care 584
N05.715.360.575.575.800 Treatment Outcome 21 703
N05.715.360.575.575.800.190 Disease-Free Survival 1 445
N05.715.360.575.575.800.379 Early Termination of Clinical Trials 16
N05.715.360.575.575.800.427 Pathologic Complete Response 7
N05.715.360.575.575.800.474 Progression-Free Survival 495
N05.715.360.575.575.800.569 Response Evaluation Criteria in Solid Tumors 42
N05.715.360.575.575.800.665 Sustained Virologic Response 19
N05.715.360.575.575.800.713 Therapeutic Index 6
N05.715.360.575.575.800.713.500 Therapeutic Index, Drug 6
N05.715.360.575.575.800.737 Treatment Effect Heterogeneity
N05.715.360.575.575.800.749 Treatment Expectations
N05.715.360.575.575.800.760 Treatment Failure 673

Add

Narrower terms